Deviation Report - QIP

4th November, 2026 To, To, The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE), Phiroze Jheejheebhoy Towers, Exchange Plaza, Dalal Street, 5th Floor Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS Dear Sir/ Madam Sub: Statement of deviation or variation for the quarter ended 30th September, 2026 Ref: Funds raised through Qualified Institutional Placement. Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended read with SEBI circular no. CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that during the quarter ended on 30th September, 2026, there was NIL deviation or variation in the utilisation of proceeds of funds raised through Qualified Institutional Placement from the objects stated in Placement Document dated 19th June, 2026 (‘PD’). A statement of deviation or variation, if any, for the quarter ended on 30th September, 2026, duly reviewed by the Audit Committee of the Company is enclosed herewith. Kindly take the above on your records. Thanking You, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J. R Company Secretary and Compliance Officer Statement of Deviation / Variation in Utilisation of Funds Particulars Details Name of listed entity Krishna Institute of Medical Sciences Limited Mode of Fund Raising Public Issue / Rights Issue / Preferential Issue / QIP / Others] Date of Raising Funds 19th June, 2026 Amount Raised Rs. 1500 Cr Report filed for Quarter ended 30th September, 2026 Monitoring Agency Applicable Monitoring Agency Name (if applicable) CARE Ratings Limited Is there a Deviation / Variation in use of funds? If yes, whether the same is pursuant to change in terms of a contract or objects, Not Applicable which was approved by the shareholders If yes, Date of shareholder approval Not Applicable Explanation for the deviation / variation Not Applicable The Audit Committee in its meeting held on 4th November, Comments of the Audit Committee after 2026, noted that there is NIL deviation or variation in the review utilisation of funds raised from the objects stated in the offer document. Comments of the auditors, if any None Objects for which funds have been raised and where there has been a deviation, in the following table: Amount of Deviation/V Modified Original Modified Funds ariation for Remarks Original Object Object, if Allocation allocation, Utilised the quarter if any any Rs. Crore if any Rs. Crore according to applicable object Repayment and/or prepayment of certain outstanding borrowings, in full 910.00 910.00 N.A. N.A. Nil or part, availed by KIMS Investment into certain Subsidiaries, namely Chalasani Hospitals Pvt Ltd, KIMS Hospitals Pvt Ltd and KIMS Hospital Bengaluru Pvt Ltd, for 215.00 215.00 repayment or prepayment, in full or in N.A. N.A. Nil part, of certain outstanding borrowings availed by such Subsidiaries General Corporate Purposes N.A. 351.45 NA 186.81 Nil Issue Expenses N.A. 23.55 NA 20.19 NIL Total 1,500.00 NA 1,332.00 NIL -